Treatment With Tissue Plasminogen Activator and Inpatient Mortality Rates for Patients With Ischemic Stroke Treated in Community Hospitals

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Stroke

• Publication date

  2001-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1161/01.STR.32.8.1832PMID 11486113
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Utilization of Intravenous Tissue-Type Plasminogen Activator for Ischemic Stroke at Academic Medical Centers: The Influence of Ethnicity

  2001cited by this paper
• NATIONAL COALITION TO REFOCUS EFFORTSIN RESPONSE TO BRAIN ATTACKS

  2001cited by this paper
• Community use of intravenous tissue plasminogen activator for acute stroke: results of the brain matters stroke management survey.

  2001cited by this paper
• Thrombolytic Therapy for Stroke

  2000cited by this paper
• Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study.

  2000cited by this paper
• Effectiveness of t-PA in acute ischemic stroke

  2000cited by this paper
• Intravenous tissue plasminogen activator for acute ischemic stroke in patients aged 80 years and older : the tPA stroke survey experience.

  2000cited by this paper
• Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience.

  2000cited by this paper
• Treating acute stroke patients with intravenous tPA. The OSF stroke network experience.

  2000cited by this paper
• Racial variation in treatment for transient ischemic attacks: impact of participation by neurologists.

  2000cited by this paper
• Thrombolytic therapy for ischemic stroke: from clinical trials to clinical practice.

  2000cited by this paper
• Age Differences in Care Practices and Outcomes for Hospitalised Patients with Cancer

  2000cited by this paper
• Potential for treatment with thrombolysis in an Irish stroke unit.

  1999cited by this paper
• Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: A multicenter survey

  1999cited by this paper
• Thrombolytic therapy for acute ischemic stroke: why the majority of patients remain ineligible for treatment.

  1999cited by this paper
• Initial clinical experience with IV tissue plasminogen activator for acute ischemic stroke: a multicenter survey. The t-PA Stroke Survey Group.

  1999cited by this paper
• Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke.

  1999cited by this paper
• Race, presenting signs and symptoms, use of carotid artery imaging, and appropriateness of carotid endarterectomy.

  1999cited by this paper
• Effects of tissue plasminogen activator for acute ischemic stroke at one year

  1999cited by this paper
• Acute stroke: delays to presentation and emergency department evaluation.

  1999cited by this paper
• Stroke mortality in blacks. Disturbing trends.

  1999cited by this paper
• Effects of tissue plasminogen activator for acute ischemic stroke at one year. National Institute of Neurological Disorders and Stroke Recombinant Tissue Plasminogen Activator Stroke Study Group.

  1999cited by this paper
• Intravenous tissue plasminogen activator for acute ischemic stroke: feasibility, safety, and efficacy in the first year of clinical practice.

  1998cited by this paper
• Predicting in-hospital deaths from coronary artery bypass graft surgery. Do different severity measures give different predictions?

  1998cited by this paper
• Early intravenous thrombolysis for acute ischemic stroke in a community-based approach.

  1998cited by this paper
• Intravenous t‐PA for acute ischemic stroke

  1998cited by this paper
• Generalized efficacy of t-PA for acute stroke. Subgroup analysis of the NINDS t-PA Stroke Trial.

  1997cited by this paper
• Patients' awareness of stroke signs, symptoms, and risk factors.

  1997cited by this paper
• Total quality improvement method for reduction of delays between emergency department admission and treatment of acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1997cited by this paper
• Recent Age-Related Trends in the Use of Thrombolytic Therapy in Patients Who Have Had Acute Myocardial Infarction

  1996cited by this paper
• Gender differences and factors associated with the receipt of thrombolytic therapy in patients with acute myocardial infarction: a community-wide perspective.

  1996cited by this paper
• Racial variation in predicted and observed in-hospital death. A regional analysis.

  1996cited by this paper
• Differences in treatment of acute myocardial infarction by sex, age, and other factors (the Stanford Five-City Project).

  1996cited by this paper
• Comparison of elderly and younger patients with out-of-hospital chest pain. Clinical characteristics, acute myocardial infarction, therapy, and outcomes.

  1996cited by this paper
• Comparison of Elderly and Younger Patients With Out-of-Hospital Chest Pain

  1996cited by this paper
• Tissue plasminogen activator for acute ischemic stroke.

  1995cited by this paper
• Using severity-adjusted stroke mortality rates to judge hospitals.

  1995cited by this paper
• Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS)

  1995cited by this paper
• Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group.

  1995cited by this paper
• Ethnic Differences in Stroke Mortality Between Non‐Hispanic Whites, Hispanic Whites, and Blacks: The National Longitudinal Mortality Study

  1994cited by this paper
• Refinement of the Medicare Diagnosis-Related Groups to Incorporate a Measure of Severity

  1994cited by this paper
• Racial variations in the rates of carotid angiography and endarterectomy in patients with stroke and transient ischemic attack.

  1993cited by this paper
• Evaluation Times for Patients With In‐Hospital Strokes

  1993cited by this paper
• Delay between emergency room arrival and stroke consultation.

  1993cited by this paper
• Gender differences in the treatment and outcome of acute myocardial infarction. Results from the Myocardial Infarction Triage and Intervention Registry.

  1992cited by this paper
• Factors Delaying Hospital Admission After Stroke in Leicestershire

  1992cited by this paper
• Some Epidemiological Aspects of Stroke: Mortality/Morbidity Trends, Age, Sex, Race, Socioeconomic Status

  1992cited by this paper
• Isolated systolic hypertension in the elderly.

  1990cited by this paper
• [Isolated systolic hypertension in the elderly].

  1989cited by this paper

• Study on the Efficacy and Pharmacological Mechanism of Innate Immune STING Pathway Regulators in the Treatment of Ischemic Brain Injury

  2025influential citation
• Histotripsy: A novel non-invasive ultrasound technology for precision thrombolysis in acute ischemic stroke management.

  2025cites this paper
• Prognostic value of combining 24-hour ASPECTS and hemoglobin to red cell distribution width ratio to the THRIVE score in predicting in-hospital mortality among ischemic stroke patients treated with intravenous thrombolysis

  2024cites this paper
• Sex Specific Outcomes After Ischemic Stroke.

  2024cites this paper
• Trends in Stroke Thrombolysis Care Metrics and Outcomes by Race and Ethnicity, 2003-2021

  2024cites this paper
• Roadmap for Health Equity: Understanding the Importance of Community-Engaged Research.

  2024cites this paper
• The impact of race and ethnicity on acute telestroke care: A multistate experience

  2023cites this paper
• Research progress of plant‐derived natural alkaloids in central nervous system diseases

  2023cites this paper
• Relationships among hospital acute ischemic stroke volumes, hospital characteristics, and outcomes in the US.

  2023cites this paper
• Neuroprotective approach in acute ischemic stroke: A systematic review of clinical and experimental studies

  2022cites this paper
• Utilizing Implementation Science to Bridge Cerebrovascular Health Disparities: a Local to Global Perspective

  2022cites this paper
• Mitigated Oxidative Stress and Cognitive Impairments in Transient Global Ischemia using Niosomal Selegiline-NBP delivery

  2022influential citation
• Acute Ischemic Stroke Presentation, Natural History, and Treatment

  2022cites this paper
• GRP per capita and hospital characteristics associated with intravenous tissue plasminogen activator adherence rate: evidence from the Chinese Stroke Center Alliance

  2021cites this paper
• Quality and safety of Telemedicine in acute ischemic stroke: Early experience in Taiwan.

  2021cites this paper
• A narrative review of stroke incidence, risk factors and treatment in Indigenous Peoples of the world

  2021cites this paper
• Telemedicine is improving outcomes for patients with stroke

  2020cites this paper
• Dapsone prolong delayed excitotoxic neuronal cell death by interacting with proapoptotic/survival signaling proteins.

  2020cites this paper
• POTENTIAL HERBAL DRUGS FOR ISCHEMIC STROKE : A REVIEW

  2020cites this paper
• Post-treatment with Posiphen Reduces Endoplasmic Reticulum Stress and Neurodegeneration in Stroke Brain

  2020cites this paper
• Umieralność wewnątrzszpitalna w okresie 5-letnim wśród chorych neurologicznych — retrospektywne, jednoośrodkowe badanie

  2020cites this paper
• Nattospes as Effective and Safe Functional Supplements in Management of Stroke

  2020cites this paper
• WNK-SPAK/OSR1-CCC signaling in ischemic brain damage

  2020cites this paper
• Wake-Promoting Effect of Bloodletting Puncture at Hand Twelve Jing-Well Points in Acute Stroke Patients: A Multi-center Randomized Controlled Trial

  2020cites this paper
• Disparities in Stroke Care: A Framework for an Integrated Care Model

  2019cites this paper
• Gender and thrombolysis therapy in acute ischemic stroke patients with incidence of obesity

  2019cites this paper
• The Association between Presentation by EMS and EMS Prenotification with Receipt of Intravenous Tissue-Type Plasminogen Activator in a State Implementing Stroke Systems of Care

  2019cites this paper
• Neuroprotective agents in Acute Ischemic Stroke-A Reality Check.

  2019cites this paper
• Comparing the Quality of Life in Patients with Stroke Under the Treatment with and Without Recombinant Tissue Plasminogen Activator

  2019cites this paper
• Factors Mediating Outcome After Stroke: Gender, Thrombolysis, and Their Interaction

  2018cites this paper
• The Influence of Sex in Stroke Thrombolysis: A Systematic Review and Meta-Analysis

  2018cites this paper
• Pharmacological thrombolysis for acute ischemic stroke treatment: Gender differences in clinical risk factors.

  2018cites this paper
• Better Outcomes and Reduced Hospitalization Cost are Associated with Ultra-Early Treatment of Ruptured Intracranial Aneurysms: A US Nationwide Data Sample Study

  2018cites this paper
• Prognostic factors in patients with acute ischemic stroke treated with intravenous tissue plasminogen activator: The first study among Iranian patients

  2018cites this paper
• Organizational models for thrombolysis in acute ischemic stroke

  2018cites this paper
• A Community-Partnered Approach to Inform a Culturally Relevant Health Promotion Intervention for Stroke

  2018cites this paper
• Treatments to Promote Neural Repair after Stroke

  2018cites this paper
• One-Month Mortality of Acute Cerebral Infarctions and its Predictive Factors in African Low-Income Country: Case of Ouagadougou in Burkina Faso

  2018cites this paper
• Sex differences in stroke: Review of current knowledge and evidence

  2017cites this paper
• Sex differences in the impact of acute stroke treatment in a population-based study: a sex-specific propensity score approach.

  2017cites this paper
• Because Women's Lives Matter, We Need to Eliminate Gender Bias.

  2017cites this paper
• Pseudoginsenoside‐F11 attenuates cerebral ischemic injury by alleviating autophagic/lysosomal defects

  2017cites this paper
• Association of centre volume and in-hospital mortality in heart failure hospitalisations

  2017cites this paper
• THE EFFECT OF TPA ON IN-HOSPITAL MORTALITY IN PATIENTS HOSPITALIZED WITH ISCHEMIC STROKE IN FLORIDA FROM 2008-2012

  2017cites this paper
• Why are acute ischemic stroke patients not receiving IV tPA?

  2016cites this paper
• A call for formal telemedicine training during stroke fellowship

  2016cites this paper
• Focus on Extracellular Vesicles: Physiological Role and Signalling Properties of Extracellular Membrane Vesicles

  2016cites this paper
• Therapeutics targeting the inflammasome after central nervous system injury.

  2016cites this paper
• Are There Disparities in Thrombolytic Treatment and Mortality in Acute Ischemic Stroke in the Hispanic Population Living in Border States versus Nonborder States?

  2016cites this paper
• Post‐treatment with cocaine‐ and amphetamine‐regulated transcript enhances infarct resolution, reinnervation, and angiogenesis in stroke rats – an MRI study

  2016cites this paper
• Comment: Telemedicine training during stroke fellowship

  2016cites this paper
• Restriction of therapy mainly explains lower thrombolysis rates in reduced stroke service levels

  2016cites this paper
• Increase in national intravenous thrombolysis rates for ischaemic stroke between 2005 and 2012: is bigger better?

  2016influential citation
• Charlson comorbidity index as a predictor of in-hospital death in acute ischemic stroke among very old patients: a single-cohort perspective study

  2016cites this paper
• Diagnostic Procedures, Treatments, and Outcomes in Stroke Patients Admitted to Different Types of Hospitals

  2015cites this paper
• Therapeutic hypothermia for stroke: Where to go?

  2015cites this paper
• How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care

  2015influential citation
• Racial Disparities in Intravenous Recombinant Tissue Plasminogen Activator Use Persist at Primary Stroke Centers

  2015cites this paper
• Outcomes of Spoke-Retained Telestroke Patients Versus Hub-Treated Patients After Intravenous Thrombolysis: Telestroke Patient Outcomes After Thrombolysis

  2015cites this paper
• The Effect of Emergency Medical Service Use and Inter-hospital Transfer on Prehospital Delay among Ischemic Stroke Patients: A Multicenter Observational Study

  2015cites this paper
• Introduction of a telemedicine support system that uses a smartphone and the internet to treat patients with acute stroke in medically under-served areas

  2015cites this paper
• Variation in Risk-Standardized Mortality of Stroke among Hospitals in Japan

  2015cites this paper
• Parecoxib Protects Mouse Cortical Neurons Against OGD/R Induced Neurotoxicity by Up-Regulating Bcl-2

  2015cites this paper
• Attributes of Non-Hispanic Blacks That Use Chiropractic Health Care: A Survey of Patients in Texas and Louisiana.

  2015cites this paper
• Factores pronósticos asociados al conocimiento y percepción de gravedad de la enfermedad cerebrovascular en la población general de Extremadura

  2015cites this paper
• Agreement between ambulance nurses and physicians in assessing stroke patients

  2014cites this paper
• The Incidence and Risk Factors of Associated Acute Myocardial Infarction (AMI) in Acute Cerebral Ischemic (ACI) Events in the United States

  2014cites this paper
• Neuroprotection in Stroke: Past, Present, and Future

  2014cites this paper
• Methodology for a Community-Based Stroke Preparedness Intervention: The Acute Stroke Program of Interventions Addressing Racial and Ethnic Disparities Study

  2014cites this paper
• MR-Guided Focused Ultrasound for Acute Stroke: A Rabbit Model

  2013cites this paper
• Pharmaco-proteomics opportunities for individualizing neurovascular treatment

  2013cites this paper
• Prehospital stroke diagnosis and treatment in ambulances and helicopters-a concept paper.

  2013cites this paper
• The Association of Hospital Volume With Mortality and Costs of Care for Stroke in Japan

  2013cites this paper
• Neuroprotective agents in ischemic stroke: past failures and future opportunities

  2013cites this paper
• Influence of The Education and Training of Prehospital Medical Crews on Measures of Performance and Patient Outcomes

  2013cites this paper
• Racial and Ethnic Differences in Outcomes in Older Patients With Acute Ischemic Stroke

  2013cites this paper
• Utilization of Intravenous Thrombolysis is Increasing in the United States

  2013cites this paper
• Systems From the American Stroke Association's Task Force on the Development of Stroke Recommendations for the Establishment of Stroke Systems of Care : Recommendations

  2013cites this paper
• Organizational models for thrombolysis in acute ischemic stroke

  2013cites this paper
• Racial and ethnic disparities in the use of intravenous recombinant tissue plasminogen activator and outcomes for acute ischemic stroke.

  2013cites this paper
• Trombólise intravenosa para o acidente vascular cerebral isquêmico agudo em um hospital brasileiro, público e acadêmico: caracterização de casuística

  2013cites this paper
• National survey of thrombolytic therapy for acute ischemic stroke in Taiwan 2003-2010.

  2013cites this paper
• [Impact of a stroke-unit on rtPA use in a community hospital: a 3-year prospective study].

  2013cites this paper
• Thrombolysis in Acute Ischemic Stroke: A Simulation Study to Improve Pre- and in-Hospital Delays in Community Hospitals

  2013cites this paper
• Stroke literacy, behavior, and proficiency in a South Florida population.

  2013cites this paper
• Higher Stroke Unit Volume Associated With Improved Quality of Early Stroke Care and Reduced Length of Stay

  2012cites this paper
• [Reliability of stroke diagnosis in emergency departments].

  2012cites this paper
• Quels sont les facteurs influençant les délais d’admission des patients arrivant aux urgences pour une suspicion d’accident vasculaire cérébral

  2012cites this paper
• [Telemedicine and fibrinolysis in Franche-Comté].

  2012cites this paper
• Proportion of Patients Treated With Thrombolysis in a Centralized Versus a Decentralized Acute Stroke Care Setting

  2012cites this paper
• Pre‐hospital delays and intravenous thrombolysis in urban and rural areas

  2012cites this paper
• Stroke Fast Track Reduces Time Delay to Neuroimaging and Increases Use of Thrombolysis in an Academic Medical Center in Thailand

  2012cites this paper
• Repair-Based Therapies After Stroke

  2012cites this paper
• Reliability of stroke diagnosis in emergency departments

  2012cites this paper
• Quality of life of elderly ischaemic stroke patients one year after thrombolytic therapy. A comparison between patients with and without thrombolytic therapy

  2012cites this paper
• Delay in Presentation After an Acute Stroke in a Multiethnic Population in South London: The South London Stroke Register

  2012cites this paper
• [What are the crucial factors affecting the time to admission of patients with suspected stroke to the emergency department?].

  2012cites this paper
• 長崎県離島発症の急性期脳梗塞患者に対するrt-PA投与～ヘリコプター搬送による“drip-and-ship”法の試み～

  2012cites this paper
• Use of thrombolytic therapy beyond current recommendations for acute ischaemic stroke

  2012cites this paper
• Application of proteomics to cerebrovascular disease

  2012cites this paper